In an article published in the Harvard Business Review, Joel Dudley, PhD, Mount Sinai Professor in Biomedical Data Science at the Icahn School of Medicine at Mount Sinai and Executive Vice President for Precision Health for the Mount Sinai Health System, and Samir Parekh, MD, Associate Professor, Medicine (Hematology and Medical Oncology), and Oncological Sciences, write about the unique partnership between researchers and doctors at Mount Sinai who are using advanced computer analytics to treat blood and bone marrow cancers.
“The Mount Sinai Health System is organized differently from most, as one integrated institution. Doctors from the seven Mount Sinai hospitals work side by side with researchers from the Icahn School of Medicine at Mount Sinai,” the authors write.
“Indeed, many clinicians also have Sinai research labs. If a clinician and a researcher devise a viable idea to solve a medical problem, they are free to join forces and pursue the project. This makes it possible to rapidly bring a finding from the lab bench to the patient bedside.”